Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time to sit up and take notice of the sector, not to mention the broader grey economy.
Related Posts
This is the lady responsible for helping improve USD50 billion Indian pharma’s quality
Sarah McMullen, USFDA India director Synopsis In the past, many within the Indian pharma industry looked at US FDA audits…
Cyriac Abby Philips: Intermittent fasting has benefits in diabetes, but is overrated like fad diets: Liverdoc Philips
Liver specialist Cyriac Abby Philips says there are no approved medicines for treating NASH or non-alcoholic steatohepatitis. Synopsis November 14…
Sun Pharma, Torrent, Alkem under lens for inferior medicines. It points to a leaky supply chain.
In the crosshairs of the latest controversy on whether a drug is spurious or “not of standard quality” is the…